Get started
Author

Kathrin Davari

Observed names: Davari, Kathrin, K. Davari
Institution: Medigene (Germany)
ORCID: 0000-0002-1250-6303
Observed ORCID: 0000-0002-1250-6303
OpenAlex ID: A5072111067
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
2021 · Kathrin Davari, Tristan Holland, et al. · Journal for ImmunoTherapy of Cancer · 53
PDF
Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3
2019 · Matthias von Gamm, Annalisa Schaub, et al. · The Journal of Experimental Medicine · 44
PDF
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis
2017 · Sonja Reißig, Yilang Tang, et al. · Nature Communications · 37
PDF
Rapid Genome-wide Recruitment of RNA Polymerase II Drives Transcription, Splicing, and Translation Events during T Cell Responses
2017 · Kathrin Davari, Johannes Lichti, et al. · Cell Reports · 36
PDF
Analysis of SHPRH functions in DNA repair and immunoglobulin diversification
2014 · Nils-Sebastian Tomi, Kathrin Davari, et al. · DNA repair · 13
Checkpoint kinase 1 negatively regulates somatic hypermutation
2014 · Samantha Frankenberger, Kathrin Davari, et al. · Nucleic Acids Research · 13
PDF
Checkpoint kinase 2 is required for efficient immunoglobulin diversification
2014 · Kathrin Davari, Samantha Frankenberger, et al. · Cell Cycle · 11
PDF
PARP activation promotes nuclear AID accumulation in lymphoma cells
2016 · Sandra Tepper, Julia Jeschke, et al. · Oncotarget · 8
PDF
161 Development of a CD8 co-receptor independent T cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T cell-based immunotherapy
2020 · Kathrin Davari, Tristan Holland, et al. · Journal for ImmunoTherapy of Cancer · 5
PDF
2249P Mitigation of tumor microenvironment-mediated immunosuppression using a PD1-41BB switch protein with optimal affinity tcrs for first-in-class, 3rd generation TCR-T therapies
2023 · K. Crame, G. Longinotti, et al. · Annals of Oncology · 1
PDF
Abstract 4057: T cells co-expressing a highly potent NY-ESO-1-specific TCR and a chimeric PD1-41BB co-stimulatory switch receptor show a favorable polyfunctional profile for the treatment of solid tumors
2023 · Andrea Coluccio, Stefanie Tippmer, et al. · Cancer Research · 1
Real-time Analysis of Transcription Factor Binding, Transcription, Translation, and Turnover to Display Global Events During Cellular Activation
2018 · Kathrin Davari, Johannes Lichti, et al. · Journal of Visualized Experiments · 1
PDF
1043P Advancing a multi-dimension KRAS mutation-specific T cell receptor (TCR) library with a 3S TCR targeting the G12D mutation to address large global patient populations
2024 · K. Crame, D. Alterauge, et al. · Annals of Oncology
PDF
Abstract 12: TCR-gated control of costimulatory switch protein (CSP) activation in rTCR-T cells expressing PD1-41BB
2024 · Maja Buerdek, Petra U. Prinz, et al. · Cancer Research
388 A novel library of optimal affinity KRAS mutation-specific T cell receptors associated with multiple HLAs, in combination with a PD1–41BB armoring and enhancement costimulatory switch receptor
2023 · Dolores Schendel, Giulia Longinotti, et al. · Journal for ImmunoTherapy of Cancer
PDF
PRAME mRNA Expression in AML/MDS and HLA Genotype Analysis: Impact on Population Coverage and Design of TCR-Based Immunotherapies
2020 · Richard Addo, Kathrin Davari, et al. · Blood
Regulation of immunoglobulin diversification by checkpoint signalling
2015 · Kathrin Davari · Common Library Network (Der Gemeinsame Bibliotheksverbund)
PDF
Works count: 19
Citation count: 223
H-index: 8
I10-index: 7
Year
Topic
Type